Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Targeted Oncology|December 21, 2016
Immuno-Oncology: The Third Paradigm in Early Drug DevelopmentJuan Martin-Liberal, Cinta Hierro, Maria Ochoa de Olza, et al.Seminars in Oncology|November 29, 2015
The Personalization of Therapy: Molecular Profiling Technologies and Their ApplicationJorge Zeron-Medina, Maria Ochoa de Olza, Irene Braña, et al.Journal for Immunotherapy of Cancer|July 14, 2022
Low-dose irradiation for reversing immunotherapy resistance: how to translate?Maria Ochoa-de-Olza, Jean Bourhis, George Coukos, et al.Current Opinion in Biotechnology|September 4, 2020
High versus low dose irradiation for tumor immune reprogrammingMaria Ochoa de Olza, Jean Bourhis, Melita Irving, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
Agnostic-Histology Approval of New Drugs in Oncology: Are We Already There?Cinta Hierro, Ignacio Matos, Juan Martin-Liberal, et al.International Journal of Molecular Sciences|February 4, 2021
Tumor-Associated Microbiome: Where Do We Stand?Marc Oliva, Nuria Mulet-Margalef, Maria Ochoa-De-Olza, et al.Human Gene Therapy|September 21, 2018
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma PatientsMargarita García, Rafael Moreno, Marta Gil-Martin, et al.Journal for Immunotherapy of Cancer|August 28, 2020
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytesAngela Orcurto, Andreas Hottinger, Benita Wolf, et al.Cancer Management and Research|October 29, 2020
PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone AcetateSofia España, Maria Ochoa de Olza, Nuria Sala, et al.Pageof 3